Clinical Trials Contact Us Careers Search Investors & Media NASDAQ: BMRN Loading... EVENTS / DECEMBER 1 Evercore ISI 4th Annual HealthCONx Conference Add to Calendar Set Email Reminder All Events PRESS RELEASES / NOV 30, 2021 BioMarin to Hold Virtual R&D Day at 11:00am ET Today All Press Releases QUARTERLY RESULTS Doc Q3 2021 Financial Results Press Release Call Q3 2021 Financial Results Conference Call All Financial Information R&D Day 2021 Investor Resources SEC Filings Email Alert Sign-Up Company Snapshot Analyst Coverage List of Stockholders as of Record Date for 2021 Annual Meeting A commitment to corporate responsibility. We are committed to conducting our operations and managing our products in a responsible manner and in accordance with applicable laws, rules, and regulations. We regularly review our operations to improve efficiency and reduce environmental impact where appropriate. Learn More We take on the biggest challenges in rare disease. Each drug candidate we pursue is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address. Learn More Contact Us Investor Relations 415-382-5731 IR@BMRN.com Media & Press 415-455-7451 corporatecommunications2@BMRN.com Email Alerts Sign up for alerts to receive updates on company announcements, financial information and more! Subscribe Navigate Our Motivation Our Treatments Our Company Investors & Media About Our History Our Products Our Pipeline Leadership Team Board of Directors Diversity, Equity & Inclusion Contact Global Contact Information Our Locations Report a Product Complaint Report Adverse Event Publication Data Request Funding & Support Connect Careers LinkedIn Facebook Instagram YouTube Privacy Policy Terms of Use Site Map Supplier Information Slavery Act Statement Glossary Contact Us © 2021 BioMarin. All rights reserved.